Top

Acta Neurochirurgica

Published in:

01-03-2017 | Review Article - Forthcoming Meeting

An update on idiopathic intracranial hypertension

Authors: Mark Portelli, Panagiotis N. Papageorgiou

Published in: Acta Neurochirurgica | Issue 3/2017

Abstract

Background

Idiopathic intracranial hypertension (IIH) is still a grey area in the knowledge of the aetiology, diagnosis and management of neurosurgical diseases. The definition of IIH has been reviewed over time and many hypotheses have been expressed as cause of the disease. The literature supplies very little evidence-based information to guide our decision-making process when it comes to treat the disease. In this review we sum up the latest information regarding the aetiology and therapy of IIH. Additionally, we make an attempt to unify the diagnostic criteria of Dandy, Friedman and Wall established from 1937 to date.

Method

In this narrative review, we attempt to update the current standpoint to IIH, evaluate the input until now and consider future directions for research. The vast majority of the literature consisted of cohort studies, case control studies, systematic reviews and other narrative reviews.

Results

Pathophysiology: The incidence of IIH is steadily increasing. Several pathophysiological theories have been proposed in the literature based on the flow of cerebrospinal fluid. Diagnosis: We attempt to fuse all the three diagnostic approaches published in the literature that detect IIH, while preserving the individual characteristics of each approach. Treatment: Based on evidence-based trials, the current use of acetazolamide in comparison with placebo or with topiramate has been evaluated. In the interventions’ field, there seems to be a consonance about the alarming symptoms and what the most suitable operation is in each case. There is some disagreement about the indications for venous sinus transversus stenting and its risk/benefit ratio.

Conclusions

Until now there is no class I guideline to which our decision-making can be based on for the management of IIH. A lack of systematic reviews and randomised control trials has been noted. If we focused our research on that, we could develop a standardised treatment protocol.

Aboul Enein HA, Abo Khair AF (2008) Idiopathic intracranial hypertension in children: clinical presenations and management. Middle East Afr J Ophthalmol 15(3):113–116CrossRefPubMed

Baker RS, Baumann RJ, Buncic JR (1989) Idiopathic intracranial hypertension (pseudomotor cerebri) in pediatric patients. Pediatr Neurol 5(1):5–11CrossRefPubMed

Smith JL (1985) Whence pseudotumour cerebri? J Clin Neuroopthalmol 5(1):55–56

Baykan B, Ekizoglu E, Altiokka UG (2015) An update on the pathophysiology of idiopathic intracranial hypertension alias pseudomotor cerebri. Agri 27(2):63–72PubMed

Soler D, Cox T, Bullock P, Calver DM, Robinson RO (1998) Diagnosis and management of benign intracranial hypertension. Arch Dis Child 78:89–94CrossRefPubMedPubMedCentral

Donaldson JO (1981) Pathogenesis of pseudotumour cerebri syndromes. Neurology 31:877–880CrossRefPubMed

Malm J, Kristensen B, Markgren P, Ekstedt J (1992) CSF hydrodynamics in idiopathic intracranial hypertension: a long term study. Neurology 42:851–858CrossRefPubMed

Radhakrishnan K, Thacker AK, Bohlaga NH, Gerryo SE (1993) Epidemiology of Idiopathic intracranial hypertension. A prospective case–control study. J Neurol Sci 116(1):18–28CrossRefPubMed

Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 18(10):1266–1268CrossRefPubMed

10.

Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, Preechawat P, Corbett JJ, Newman NJ, Biousse V (2009) Idiopathic intracranial hypertension in men. Neurology 72(4):304–309CrossRefPubMedPubMedCentral

11.

Kesler A, Gadoth N (2001) Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 21(1):12–14CrossRefPubMed

12.

Biousse V, Bruce BB, Newman NJ (2012) Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 83(5):488–494CrossRefPubMedPubMedCentral

13.

Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, Mejico LJ, Volpe NJ, Galetta SL, Balcer LJ, Liu GT (2011) Weight gain and recurrence in idiopathic intracranial hypertension: a case control study. Neurology 76(18):1564–1567CrossRefPubMed

14.

Karaman K, Gverovic-Antunica A, Zuljan I, Vukojevic N, Zoltner B, Erceg I, Ivkosic A (2003) Familial idiopathic intracranial hypertension. Croat Med J 44(4):480–484PubMed

15.

Kharode C, McAbee G, Sherman J, Kaufman M (1992) Familial intracranial hypertension: report of a case and review of the literature. J Child Neurol 7(2):196–198CrossRefPubMed

16.

Corbett JJ (2008) The first Jacobson Lecture. Familial idiopathic intracranial hypertension. J Neuroophthalmol 28(4):337–347CrossRefPubMed

17.

Chebel S, Boughammoura-Bouatay A, Ammar M, Frih-Ayed M (2009) Familial presentation of idiopathic intracranial hypertension. J Neuro-Ophthalmol 33(1–2):65–67CrossRef

18.

Bidot S, Saindane AM, Pergallo JH, Bruce BB, Newman NJ, Biousse V (2015) Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmol 35(4):400–411

19.

Babikan P, Corbett J, Bell W (1994) Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol 9:144–149CrossRef

20.

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693–701CrossRefPubMedPubMedCentral

21.

Best J, Silvestri G, Burton B, Foot B, Acheson J (2013) The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J 7:26–29CrossRefPubMedPubMedCentral

22.

Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 87(9):982–992CrossRefPubMedPubMedCentral

23.

Wall M, George D (1991) Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114(Pt 1A):155–180PubMed

24.

Becker N, Kronenberg G, Harms L, Wiener E, Kreutz K, Eltiri A, Schmidt F, Hoffmann J, Kunte H (2016) Rapid improvement of olfaction after lumbar puncture in a patient with idiopathic intracranial hypertension. Headache. doi:10.1111/head.12802

25.

Bershad EM, Urfy MZ, Calvillo E, Tang R, Cajavilca C, Lee AG, Venkatasubba Rao CP, Suarez JI, Chen D (2014) Marked olfactory impairment in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 85(9):959–964CrossRefPubMed

26.

Liu Z, Dong C, Wang X, Han X, Zhao P, Lv H, Li Q, Wang Z (2015) Association between idiopathic intracranial hypertension and sigmoid sinus dehiscence/diverticulum with pulsatile tinnitus: a retrospective imaging study. Neuroradiology 57(7):747–753CrossRefPubMed

27.

Friedman DI (2014) The pseudotumor cerebri syndrome. Neurol Clin 32(2):363–396CrossRefPubMed

28.

Kleinschmidt JJ, Digre KB, Hanover R (2000) Idiopathic intracranial hypertension: relationship to depression, anxiety, and quality of life. Neurology 54(2):319–324CrossRefPubMed

29.

Liguori C, Romigi A, Albanese M, Marciani MG, Placidi F, Friedman D, Digre K, Liu G (2014) Revised diagnostic criteria for the pseudomotor cerebri syndrome in adults and children. Neurology 82(19):1752–1753CrossRefPubMed

30.

Kahle KT, Kulkarni AV, Limbrick DD, Warf BC (2016) Hydrocephalus in children. Lancet 387(10020):788–799CrossRefPubMed

31.

Riggeal BD, Bruce BB, Saindane AM, Ridha MA, Kelly LP, Newman NJ, Biousse V (2013) Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 15;80(3):289–295CrossRef

32.

Ball AK, Sinclair AJ, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA, Stewart PM, Nightingale PG, Clarke CE, Rauz S (2009) Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) 70(6):863–869CrossRef

33.

Lampl Y, Eshel Y, Kessler A, Fux A, Gilad R, Boaz M, Matas Z, Sadeh M (2002) Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 72(5):642–643CrossRefPubMedPubMedCentral

34.

Tabassi A, Salmasi AH, Jalali M (2005) Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 64(11):1893–1896CrossRefPubMed

35.

Warner JE, Larson AJ, Bhosale P, Digre KB, Henley C, Alder SC, Katz BJ, Bernstein PS (2007) Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 27(4):258–262CrossRefPubMed

36.

Neuro-Ophthalmology Research Disease Investigator (NORDIC) (2016) Available at: www.nordicclinicaltrials.com. Accessed 14 June 2016

37.

Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M (2015) Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results. Neurology 84(24):2449–2456CrossRefPubMedPubMedCentral

38.

Stiebel-Kalish H, Serov I, Sella R, Chodick G, Snir M (2014) Childhood overweight or obesity increases the risk of IIH recurrence fivefold. Int J Obes (Lond) 38(11):1475–1477CrossRef

39.

Jungner M, Siemund R, Venturoli D, Reinstrup P, Schalen W, Bentzer P (2016) Blood–brain barrier permeability following traumatic brain injury. Minerva Anesthesiol 82(5):525–533

40.

O’Brien NF, Maa T, Reuter-Rice K (2015) Noninvasive screening for intracranial hypertension in children with acute, severe traumatic brain injury. J Neurosurg Pediatr 16(4):420–425CrossRefPubMed

41.

Bloch O, Auguste KI, Manley GT, Verkman AS (2006) Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. J Cereb Blood Flow Metab 26(12):1527–1537CrossRefPubMed

42.

Dhungana S, Waters P, Ismail A, Woodroofe N, Vincent A, Sharrack B (2010) Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. J Neurol 257:1211–1212CrossRefPubMed

43.

Kerty E, Heuser K, Indahl UG, Berg PR, Nakken S, Lien S, Omholt SW, Ottersen OP, Nagelhus EA (2013) Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol 91(1):88–91CrossRefPubMed

44.

King LS, Nielsen S, Agre P (1996) Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat. J Clin Invest 97(10):2183–2191CrossRefPubMedPubMedCentral

45.

Skau M, Goetze JP, Rehfeld JF, Jensen R (2010) Natriuretic pro-peptides in idiopathic intracranial hypertension. Regul Pept 164(2–3):71–77CrossRefPubMed

46.

Bateman GA, Stevens SA, Stimpson J (2009) A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J Neurosurg 110:446–456CrossRefPubMed

47.

Mukherjee N, Bhatti MT (2014) Update on the surgical management of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep 14(3):438CrossRefPubMed

48.

Wong R, Madill SA, Pandey P, Riordan-Eva P (2007) Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 7:15CrossRefPubMedPubMedCentral

49.

Johnston LN, Krohel GB, Madsen RW, March GA (1998) The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudomotor cerebri). Ophthalmology 105(12):2313–2317CrossRef

50.

Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D (2011) Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg 114(1):34–39CrossRefPubMed

51.

Millichap JG, Millichap JJ (2015) Mechanism of action of acetazolamide and idiopathic intracranial hypertension. Front Neurol 6:13CrossRefPubMedPubMedCentral

52.

The NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee (2014) Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss. The Idiopathic Intracranial Hypertension Treatment Trial. JAMA 311(16):1641–1651CrossRefPubMedCentral

53.

Piper RJ, Kalyvas AV, Young AMH, Hughes MA, Jamjoom AAB, Fouyas IP (2015) Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev (8):CD003434

54.

Horton JC (2014) Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial. JAMA 311(16):1618–1619CrossRefPubMed

55.

Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, Jacks AS, Lawden M, Sivaguru A, Furmston A, Howell S, Sharrack B, Davies MB, Sinclair AJ, Clarke CE (2011) A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 258(5):874–881CrossRefPubMed

56.

Supuran CT (2015) Acetazolamide for the treatment of idiopathic intracranial hypertension. Expert Rev Neurother 15(8):851–856CrossRefPubMed

57.

Celebisoy N, Gokcay F, Sirin H, Akyurekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116(5):322–327CrossRefPubMed

58.

Thambisetty M, Lavin PJ, Newman NJ, Biousse V (2007) Fulminant idiopathic intracranial hypertension. Neurology 68(3):229–232CrossRefPubMed

59.

Feldon SE (2007) Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus 23(5), E6CrossRefPubMed

60.

Moreau A, Lao KC, Farris BK (2014) Optic nerve sheath decompression: a surgical technique with minimal operative complications. J Neuroophthalmol 34(1):34–38CrossRefPubMed

61.

Corbett JJ, Nerad JA, Tse DT, Anderson RL (1988) Results of optic nerve sheath fenestration for pseudotumor cerebri: the lateral orbitotomy approach. Arch Ophthalmol 106(10):1391–1397CrossRefPubMed

62.

Sergott RC, Savino PJ, Bosley TM (1988) Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 106(10):1384–1390

63.

Banta JT, Farris BK (2000) Pseudomotor cerebri and optic nerve sheath decompression. Ophthalmology 107(10):1907–1912CrossRefPubMed

64.

Spitze A, Malik A, Al-Zubidi N, Golnik K, Lee AG (2013) Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy? J Neuroophthalmol 33(2):183–188CrossRefPubMed

65.

Thuente DD, Buckley EG (2005) Pediatric optic nerve sheath decompression. Ophthalmology 112(4):724–727CrossRefPubMed

66.

Tarnaris A, Toma AK, Watkins LD, Kitchen ND (2011) Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin Neurol Neurosurg 113(6):477–479CrossRefPubMed

67.

Matloob SA, Toma AK, Thorne L, Watkins LD (2015) Surgically managed idiopathic intracranial hypertension in adults: a single centre experience. Acta Neurochir (Wein) 157(12):2099–2103CrossRef

68.

Arac A, Lee M, Steinberg GK, Marcellus M, Marks MP (2009) Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus 27(5), E14CrossRefPubMed

69.

Radvany MG, Solomon D, Nijjar S, Subramanian PS, Miller NR, Rigamonti D, Blitz A, Gailloud P, Moghekar A (2013) Visual and neurological outcomes following a transverse sinus stenosis. J Neuroophthalmol 33(2):117–122CrossRefPubMed

70.

Brazis PW (2008) Clinical review: the surgical treatment of idiopathic pseudomotor cerebri (idiopathic intracranial hypertension). Cephalalgia 28(12):1361–1373CrossRefPubMed

71.

Puffer RC, Mustafa W, Lanzino G (2013) Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg 5(5):483–486CrossRefPubMed

Title: An update on idiopathic intracranial hypertension
Authors: Mark Portelli
Panagiotis N. Papageorgiou
Publication date: 01-03-2017
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 3/2017
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-016-3050-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

An update on idiopathic intracranial hypertension

Abstract

Background

Method

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Method

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2017

João Lobo Antunes, 1944–2016

Muscular atrophy in severe cases of cubital tunnel syndrome: prognostic factors and outcome after surgical treatment

Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review

Spontaneous regression of a parafalcine meningioma in a multiple sclerosis patient being treated with interferon beta-1a

Delayed asymptomatic coil migrations toward different arteries after aneurysmal embolization: case report

Multiplex PCR as a novel method in the diagnosis of spinal tuberculosis–a pilot study